Pilot longitudinal study identifies gene-associated DNA methylation changes linked to glycemic progression, suggesting further validation is needed.
This pilot longitudinal study suggests that gene-associated DNA methylation changes in blood may be detectable prior to the onset of dysglycemia. These findings are exploratory and hypothesis-generating, highlighting candidate genes and epigenetic-metabolic associations for targeted validation in larger, independent cohorts using alternative analytical approaches.
No takes yet. Share an insight, caveat, or question.
Satheesh et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: